Fandango Holdings PLC (FHP) — Investment Research Note

Executive summary

Fandango Holdings is a UK-listed cash shell with no operating business, whose shares have been suspended since 2021 while it attempts to complete a reverse takeover — currently the proposed acquisition of European Battery Metals Pty Ltd ("EBM"), a Swedish battery-metals exploration vehicle, having previously aborted a 2021 RTO of Bahamian crypto/IoT business Radair Limited. Across the period covered the company has burned cash at £88k–£776k per year, accumulated £2.1m of losses, sits on net liabilities of £711k with just £1k of cash, and is wholly dependent on £671k of director/shareholder loans and a £150k post-period support facility from a director-controlled entity. The single most important valuation point is that there is no operating business to value — the equity is a call option on a still-unapproved RTO into an early-stage battery-metals asset, and the listing currency value of the shell is materially less than the disclosed market cap.

Fair value estimate

Methodology: Net asset value / shell valuation. With no trading business, the only credible anchor is the balance sheet plus the embedded value of a suspended-but-still-listed Main Market vehicle.

Inputs (from 2025-08 final results):

Net liabilities: £(711)k at 28 Feb 2025
Cash: £1k; Total assets £11k; Total liabilities £722k
Shares in issue: 134,002,000
Accrued related-party fees and loans owed to insiders dominate the liability stack (Brookborne £140k, Kinloch £86k, Longley £159k + £39k, plus £150k Tatbels facility post year-end)
£350k convertible loan note (equity reserve £672k) converts into shares on RTO completion, so will dilute meaningfully

Approach: A typical UK Main Market suspended shell with a credible RTO pipeline has historically been valued at ~£0.5m–£1.5m for the listing optionality alone, less negative net asset position. Applying this:

Shell value gross: £500k–£1,000k
Less net liabilities: £(711)k
Pre-dilution equity value: £(211)k to £289k — i.e. essentially zero to modestly positive
On 134m shares this implies a fair value of 0p to ~0.2p per share before RTO dilution
Post-RTO conversion of ~£672k convertible at any reasonable strike would heavily dilute existing holders further

Fair value range: 0p – 0.5p per share, implying a market cap range of £0.0m – £0.7m.

Comparison to disclosed market cap (£0.6m / ~0.45p): the disclosed cap sits at the top of my range. Even on the optimistic interpretation (RTO completes, listing optionality is preserved, dilution is manageable), the shares are at best fairly valued; on a more realistic interpretation, equity holders are subordinate to ~£700k of accrued insider liabilities and £670k+ convertible reserve that will dilute them.

Implied upside/downside: approximately –50% to +10% vs current. Asymmetric to the downside given the going-concern emphasis-of-matter.

Sector context

Sector classification (Financial Services / Investment Company) is technically correct per LSE designation but misleading — this is a cash shell / RTO vehicle, not an operating financial-services company. Quality, growth and leverage profile are all materially below typical Financial Services peers: no AUM, no revenue, persistent losses, net-liability balance sheet, material going-concern uncertainty. Comparable peers are other UK Main Market suspended shells pursuing RTOs — e.g. other Standard Listing cash shells managed by similar promoters in the AIM/Main Market micro-cap ecosystem. No meaningful listed comp can be cited as a valuation anchor.

Investment thesis (3 bullets)

Listing optionality: a UK Main Market listing is a scarce asset; if the EBM RTO completes, post-money equity may re-rate from a non-trading 0.45p shell to whatever the market ascribes to a small-cap Swedish battery-metals explorer 2025-08-15 final results — RTO target described as a "suite of highly prospective battery related mineral assets in Sweden".
Insider alignment via support letters: Charles Tatnall and James Longley have agreed not to call their loans until the company can repay them, and Tatbels Limited has extended a £150k interest-free facility post year-end — keeping the shell solvent while the RTO clears UKLA 2025-08-15 final results, Events after the reporting period.
Battery-metals tailwind: if the Swedish asset base is meaningful, EBM benefits from EV battery supply-chain demand — though this is investment company exposure to mining, not AI-receiver exposure, and the user's profile is explicitly looking for AI exposure rather than battery commodities 2025-08-15 final results.

Key risks (3 bullets)

Going concern / structurally negative equity: £(711)k net liability position, £1k cash, material-uncertainty going-concern statement, and an auditor "Emphasis of Matter" specifically on related-party loans 2025-08-15 final results, Going Concern.
Execution risk on RTO: management has been pursuing an RTO since 2021 — the Radair (crypto/IoT) deal collapsed and EBM has slipped from "Q1 2024" → "late September 2024" → "late September 2025", with shares suspended throughout 2023-11-28 half-year, 2024-08-02 final results, 2025-08-15 final results.
Related-party and governance signals: £393.7k of loans to director-affiliated Plutus entities were fully provided then "reassigned" against amounts owed to a director and former director — moving impairments off-balance-sheet via insiders rather than cash settlement, with the auditor flagging this 2025-08-15 final results, s.172 statement and Note 18.

Operating leverage

The company has no operating leverage in any meaningful sense — there is no trading business. Total administrative expense was £481k in FY25 against £nil operating revenue 2025-08-15 final results, Note 6. Cost base is essentially 100% fixed (directors' fees £76k, listing fees £43k, consultancy £57k, audit £59k) but there is no revenue line for it to leverage against. Even if the EBM RTO completes, the post-deal entity would be an early-stage exploration company, which is the opposite of an operationally-leveraged platform — it requires capex, sustains exploration losses, and only generates meaningful revenue (if ever) years out. The user's stated preference for capital-light, fixed-cost businesses where revenue surprises drop multiplicatively to profit is not met by this shell or its likely RTO target.

Value-trap signals

Persistent losses for at least five years with no revenue
Net-liability balance sheet (£711k negative equity) and £1k of cash
Shares suspended since 2021 — no price discovery
Material uncertainty / going-concern emphasis-of-matter
Repeated RTO target changes (Radair 2021 → group of construction/concrete companies 2020 HoT → EBM 2023) and repeated timeline slippage (Q1 2024 → late 2024 → late 2025)
Related-party loans to Plutus entities controlled by the same directors, written off then "reassigned" off-balance-sheet
Directors paid via Brookborne / Kinloch consultancy structures (controlled by the directors themselves) with £225k of accrued fees outstanding to those entities
£394k of "other income" in FY25 was a non-cash reversal of related-party loan write-offs, not operating profit
No share transactions or capital raises completed in over four years despite intent — limited market appetite

Earnings vs. expectations

The filings do not contain analyst consensus or formal management guidance to track in the conventional sense — the company has no trading business and provides no KPIs ("there is no KPI available other than the pending potential completion of the RTO" 2025-08-15 final results). What can be tracked is RTO timeline guidance vs. delivery: management guided Q1 2024 completion in November 2023, then late September 2024 in August 2024, then late September 2025 in August 2025 — three sequential slippages of ~12 months each. On the operating cost side, the company has missed its own implicit expectation of completing the RTO and stabilising — FY24 loss of £762k was materially worse than the prior 18-month loss of £142k, driven by related-party write-offs. Pattern: serial guidance misses on the only metric that matters (deal closure).

Conviction

Conviction: 4 / 5 (high) — paradoxically high, given the methodology is unambiguous: with no operating business, NAV/shell value is the only defensible approach, and the inputs (cash, liabilities, share count) are clearly disclosed. What anchors conviction: (1) the balance sheet is published and the £(711)k net liability is hard to dispute; (2) the going-concern emphasis-of-matter is explicit; (3) listed shell-value comps are well-understood in the UK micro-cap ecosystem. What limits conviction: (1) the RTO is a binary event whose terms (consideration, share-issue ratio, post-money mcap) are not disclosed, so post-completion fair value could be materially different — but that's an option value, not a fair value of the current shell; (2) the disclosed market cap of £0.6m on suspended shares is a stale data point, not a tradeable price.

Driver scoring justification

AI beneficiary (5): zero AI exposure; battery-metals RTO target is an EV supply-chain play, not an AI receiver.
Operating leverage (8): no trading business, no revenue, costs are fixed but there is nothing to leverage them against. Effectively zero.
Earnings surprise trend (10): serial guidance misses on RTO timing; persistent losses; no positive surprises in the record.
Cyclicality (50): shell is non-cyclical by definition; if RTO completes the target is battery-metals exploration, which is highly cyclical to commodity prices. Net: middle of the range.
Moat (3): the only durable asset is the Main Market listing slot — and even that is impaired by suspension.
Leverage (75): net-liability balance sheet, £722k liabilities vs £11k total assets, dependent on director-shareholder support letters and an interest-free £150k facility from a director's company. Functionally insolvent ex-support.
Earnings quality (8): £394k "other income" in FY25 is a non-cash reversal of related-party write-offs; prior-year restatement on convertible loan interest; auditor emphasis-of-matter on related-party loans.
Management quality (15): serial deal failure (Radair, construction/concrete HoTs, multi-year EBM slippage); related-party loans to director-controlled entities subsequently impaired; payments through director-owned consultancy vehicles; persistent value destruction.
Growth momentum (5): no revenue, no growth; the only "growth" is in accumulated deficit and accrued related-party liabilities.

Overall score: 35 / 1000

A near-worst-case fit for this investor profile: zero AI-receiver exposure, no operating leverage (no operations), stretched valuation relative to a defensible NAV anchor, and very weak downside protection (negative equity, going-concern uncertainty, governance flags). The only reason the score is not lower is that the listing optionality has some embedded value if the EBM RTO completes, and the absolute capital at risk for any holder is small.